# Outcome of COVID-19 patients with use of Tocilizumab: A single center experience

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/outcome-of-covid-19-patients-with-use-of-tocilizumab-a-single-center-experience/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Muhammad Zain Mushtaq,Saad Bin Zafar Mahmood,Bushra Jamil,Adil Aziz,Syed Ahsan Ali |
| Citations | 23 |
| DOI | 10.1016/j.intimp.2020.106926 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/7455148 |
| OpenAlex ID | https://openalex.org/W3080143990 |
| PMID | 32889236 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Syed Ahsan Ali](https://scholariq.org/researchers/syed-ahsan-ali/)

## Paper journal

- [International Immunopharmacology](https://scholariq.org/journals/international-immunopharmacology/)

## Paper primary topic

- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)

## Paper topics

- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Long-Term Effects of COVID-19](https://scholariq.org/topics/long-term-effects-of-covid-19/)
- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.